Is QGEN undervalued or overvalued?
As of 2025-03-16, the Intrinsic Value of Qiagen NV (QGEN) is 30.39 USD. This QGEN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 39.48 USD, the upside of Qiagen NV is -23.00%. This means that QGEN is overvalued by 23.00%.
The range of the Intrinsic Value is 17.13 - 101.34 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 17.13 - 101.34 | 30.39 | -23.0% |
| DCF (Growth 10y) | 22.10 - 118.05 | 37.29 | -5.5% |
| DCF (EBITDA 5y) | 25.49 - 35.36 | 30.03 | -23.9% |
| DCF (EBITDA 10y) | 28.82 - 41.68 | 34.62 | -12.3% |
| Fair Value | 9.67 - 9.67 | 9.67 | -75.50% |
| P/E | 11.83 - 21.26 | 16.28 | -58.8% |
| EV/EBITDA | 26.65 - 56.45 | 38.86 | -1.6% |
| EPV | 17.84 - 24.15 | 21.00 | -46.8% |
| DDM - Stable | 5.18 - 29.72 | 17.45 | -55.8% |
| DDM - Multi | 17.72 - 79.95 | 29.11 | -26.3% |
| Market Cap (mil) | 8,530.84 |
| Beta | 0.46 |
| Outstanding shares (mil) | 216.08 |
| Enterprise Value (mil) | 9,258.83 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.20% |
| Cost of Debt | 5.00% |
| WACC | 6.73% |